| 000 | 01927nam a2200397Ia 4500 | ||
|---|---|---|---|
| 001 | 265932 | ||
| 003 | OCoLC | ||
| 005 | 20160527193412.0 | ||
| 006 | m d f | ||
| 007 | cr mnu---uuaun | ||
| 008 | 040505s2004 dcua sb f000 0 eng d | ||
| 020 | _a0160715229 | ||
| 037 | _a552-070-31093-2 | ||
| 040 |
_aBUF _cBUF |
||
| 043 | _an-us--- | ||
| 049 |
_aPUXA _bev |
||
| 074 | _a1043-A | ||
| 074 | _a1043-A (online) | ||
| 074 | _a1043-B | ||
| 074 | _a1043-B (online) | ||
| 086 | 0 | _aY 4.L 11/4:S.HRG.108-378 | |
| 092 | 0 |
_a363.19473 _bF2931 _222 |
|
| 110 | 1 |
_aUnited States _bCongress. _bSenate. _bCommittee on Health, Education, Labor, and Pensions. _2Local _9182913 |
|
| 245 | 1 | 0 |
_aFederal and state role in pharmacy compounding and reconstitution _bexploring the right mix to protect patients : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, first session, on examining state and federal oversight to ensure the safety and quality of drug compounding--the process of mixing, combining, or altering ingredients to create a customized medication for an individual patient--by pharmacies, October 23, 2003. |
| 260 |
_aWashington _bU.S. G.P.O. _bFor sale by the Supt. of Docs., U.S. G.P.O. _c2004. |
||
| 300 |
_aiii, 145 p. _bill. _c24 cm. |
||
| 490 | 1 |
_aS. hrg. _v108-378 _2Local _9163536 |
|
| 500 | _a"Printed for the use of the Committee on Health, Education, Labor, and Pensions." | ||
| 500 | _aDistributed to some depository libraries in microfiche. | ||
| 500 | _aTitle from resource itself. | ||
| 504 | _aIncludes bibliographical references. | ||
| 530 | _aAlso available via the World Wide Web | ||
| 650 | 0 |
_aDrugs _xDosage forms _zUnited States _xEvaluation. _2Local _988821 |
|
| 650 | 0 |
_aPharmaceutical Industry _zUnited States _xQuality control. _2Local _9150476 |
|
| 810 | 1 |
_aUnited States. _bCongress. _bSenate. _tS. hrg. _v108-378. |
|
| 999 |
_c191761 _d191761 |
||